Now Accepting Topic Submissions for 2025. Click here to learn more.
The Largest Annual Gathering of Biotech CMOs
The CMO Summit 360° ® is the largest gathering of biotech Chief Medical Officers across indications, modalities, company stages, professional experience levels and geographic locations. This is the conference to connect with peers and develop the skills needed to succeed as a biotech CMO.
Supporting Biotech CMOs Year-Round
In addition to the annual event, we support biotech CMOs throughout the year via our editorials, podcasts and webcasts, covering all elements of the role.
Check out the latest below:
2024 Keynotes
R&D Leadership
Keynote
Mathai Mammen, MD, PhD
CEO, President & Chairman
FogPharma
AI Keynote
Dina Katabi, PhD
Thuan and Nicole Pham Professor
MIT
Drug Development
Industry Keynote
Kenneth Getz, MBA
Director of Sponsored Research / Founder
Tufts CSDD / CISCRP
Strategic Innovation
Keynote
Gary Pisano, PhD
Harry E Figgie, Jr Professor of Business Administration
Harvard Business School
Biotech Investment Banking Keynote
Michael Meyers
Vice Chairman & Head of M&A and Strategic Advisory Services H.C. Wainwright & Co., LLC
2024 Co-Chairs
Nerissa Kreher, MD, MBA
Consultant CMO
Ed Tucker, MD, MBA
CMO
Jasper Therapeutics
Anna Frostegård, MD, PhD
Co-Founder, CMO & CSO
Annexin Pharmaceuticals
"It was a fabulous event that exceeded my expectations. I really enjoyed every session and I met wonderful people who were so welcoming, kind and generous." - Eslie Dennis, Kyowa Kirin
2024 Key Themes Included
Navigating the CMO Role in 2024
• Annual Keynote Address on the State of the Drug Development Industry
• Lessons Learned Navigating Challenges and Pivoting as a CMO
• Managing and Motivating a Biotech Team in 2024
• Working Within a Budget: How to Create the Greatest Value Within a Runway Before the Next Funding Raise
• Artificial Intelligence Keynote
• The Role of AI in the CMO Clinical Development Toolbox
Best Practices Managing CMO Departments
• How CMOs Build a Network of Consultants and Support
• How Biotechs and CROs Navigate their Relationships to Advance Clinical Development
• Patient Engagement: Practical Approaches
• Maximizing Regulatory Interactions
• What CMOs Need to Know About Partnering with Hospitals & Clinical Research Sites
• Best Practices Interacting with Boards Throughout the Biotech Lifecycle
The Lifecycle of a Biotech CMO
• CEOs’ Insights on Where CMOs can Best Add Value for Companies at Different Stages
• CMO as a Translational Scientist
• Scaling Up Effectively as Your Biotech Company Evolves
• Transitioning from Early Stage to Registrational/Pivotal Stage Development
• Preparing for Launch: What CMOs Need to Know and Do
Biotech Financing and Business Development
• What Investors Are Looking For in 2024
• CMO Insights and Advice on Tailoring Your Pitch to Investors
• Best Practices Throughout the Lifecycle of Pharma-Biotech Partnerships and M&A
Professional Development for CMOs
• R&D Leadership Keynote
• Learning & Unlearning to Succeed as a CMO
• Gathering Expertise in New Indications and Modalities
• Career Paths for CMOs
Biotechs in Attendance (as of 4/15/2024)
Recognizing the Complex Role of the Chief Medical Officer
The role of a biotech Chief Medical Officer is one that means many things to many people, and indeed is radically different depending on the type of organization in which a CMO works. The CMO Summit 360° is committed to:
1. Creating a community of biotech CMOs to facilitate peer-to-peer learning and networking
2. Covering all aspects of the CMO role with over 35 sessions on clinical development, outsourcing, medical affairs, regulatory interactions, investor relations & financing, leadership & management, cross-functional collaboration and professional development
3. Presenting keynote-level discussions on R&D leadership, novel technologies, trends in clinical development and the state biotech financial environment
"The meeting was very informative and practical. The networking opportunities were excellent. I also enjoyed the opportunity to become acquainted with some of the vendors." - Howard Rutman, Xalud Therapeutics